Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|February 4, 2010
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cellsAnke Waha, Jörg Felsberg, Wolfgang Hartmann, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2007
Microsatellite instability in pediatric and adult high-grade gliomasAnika Eckert, Matthias Kloor, Antje Giersch, et al.
International Journal of Cancer|May 18, 2010
Molecular signatures classify astrocytic gliomas by IDH1 mutation statusGrischa Toedt, Sebastian Barbus, Marietta Wolter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Annals of Neurology|February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphomaUlrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
JCI Insight|January 25, 2019
Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive nicheSara Chiblak, Zili Tang, Dieter Lemke, et al.
Journal of Neuropathology and Experimental Neurology|March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expressionCornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideWolfgang Wick, Christian Hartmann, Corinna Engel, et al.
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
Pageof 8